Back to search
Beta-lactam Allergy
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Beta-lactam Allergy trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Beta-lactam Allergy trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
The overall goal of the RENEW-IN intervention is to assess the impact of a BL allergy delabeling intervention on antibiotic use and clinical outcomes in patient…
Cephalosporin antibiotics are commonly used but can result in allergic reactions and anaphylaxis. There is no clear diagnostic approach for cephalosporin-allerg…
The purpose of this study is to demonstrate the feasibility of direct oral challenge performed in private practice setting for children with suspected benign de…
Antibiotic allergy labels (AAL) are reported in 7% of inpatient's charts, especially for beta-lactams (86% of AAL, i.e., prevalence of 6%). They are associated…
The purpose of this study is to establish the rationale for the practice of performing an oral reintroduction test without previous skin tests in children at lo…
The goal of this RENEW-EVAL project is to understand the potential barriers to implementation of the RENEW intervention into the routine clinical care of patien…